Quarterly Report (10-q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: June 30, 2020

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from __________ to __________

Commission file number 000-52668

NEW YOU, INC.

(Exact name of registrant as specified in its charter)

Nevada		26-3062661
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

3246 Grey Hawk Court, Carlsbad, California 92010

(Address of principal executive offices)

(866) 611-4694

(Registrant's telephone number)

Indicate by checkmark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days x Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," “smaller reporting company," and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	x	Smaller reporting company	x
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes x No

As of August 18, 2020, there were 38,324,890 shares of the Registrant's common stock.

TABLE OF CONTENTS

Part I	Financial Information	3

Item 1.	Financial Statements	3
Item 2.	Management's Discussion And Analysis Of Financial Condition And Results Of Operations	13
Item 3.	Quantitative And Qualitative Disclosures About Market Risk	15
Item 4.	Controls And Procedures	16

Part II	Other Information	16

Item 1.	Legal Proceedings	16
Item 1A.	Risk Factors	16
Item 2.	Unregistered Sale Of Equity Securities And Use Of Proceeds	16
Item 3.	Defaults Upon Senior Securities	16
Item 4.	Mine Safety Disclosures	17
Item 5.	Other Information	17
Item 6.	Exhibits	17

PART I - FINANCIAL INFORMATION

ITEM 1.

FINANCIAL STATEMENTS

New You, Inc.
Condensed Consolidated Balance Sheets

	June 30,			December 31,
	2020			2019
		(Unaudited)
ASSETS
Current Assets:
Cash	$	1,125		$	1,125
Credit Card Receivable		6,325			23,715
Inventory		72,316			147,780
Prepaid Expenses and Other Current Assets		36,863			5,000
Total Current Assets		116,629			177,620

Property and Equipment, Net		22,468			25,795
Operating Lease Right of Use Asset, Net		75,652			96,310

TOTAL ASSETS	$	214,749		$	299,725

LIABILITIES AND STOCKHOLDERS' DEFICIT
LIABILITIES
Current Liabilities:
Accounts Payable and Other Accrued Expenses	$	446,208		$	471,507
Accounts Payable to Related Parties		78,135			200,605
Notes Payable, Current		260,428			—
Operating Lease Liability, Current		91,279			63,410
Related Party Debt		424,747			497,147
Total Current Liabilities		1,300,797			1,232,669

Noncurrent Liabilities
Operating Lease Liabilities, Noncurrent		6,204			38,025
Notes Payable, Noncurrent		63,530			—
Total Noncurrent Liabilities		69,734			38,025

TOTAL LIABILITIES		1,370,531			1,270,694

COMMITMENTS AND CONTINGENCIES - SEE NOTE 6

STOCKHOLDERS’ DEFICIT
Common stock at $0.00001 par value: 1,400,000,000 shares authorized as of June 30, 2020 and December 31, 2019; 38,279,890 and 32,985,200 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively		383			330
Additional Paid-in Capital		3,084,528			1,149,005
Accumulated Deficit		(4,240,693	)		(2,120,304	)
TOTAL STOCKHOLDERS' DEFICIT		(1,155,782	)		(970,969	)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	214,749		$	299,725

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

New You, Inc.
Condensed Consolidated Statements of Operations

	For The Three Months Ended						For The Six Months Ended
	June 30,						June 30,
	2020			2019			2020			2019
	(Unaudited)			(Unaudited)			(Unaudited)			(Unaudited)
Revenue	$	544,600		$	729,004		$	1,076,123		$	1,458,901

Cost of Goods Sold		50,007			130,146			131,849			300,864

Gross Profit		494,593			598,858			944,274			1,158,037

Selling, General and Administrative Expenses
Commission Expense		161,954			270,787			309,644			474,315
Stock Based Compensation		695,660			—			1,460,576			—
Other		301,234			541,147			770,310			873,727
Total Selling, General and Administrative Expenses		1,158,848			811,934			2,540,530			1,348,042

Loss from Operations		(664,255	)		(213,076	)		(1,596,256	)		(190,005	)

Interest Expense		491,400			—			523,333			—

Net Loss before Income Tax Expense		(1,155,655	)		(213,076	)		(2,119,589	)		(190,005	)

Income Tax Expense		—			—			800			800

Net Loss	$	(1,155,655	)	$	(213,076	)	$	(2,120,389	)	$	(190,805	)


Net Loss Per Common Share
- Basic and Diluted	$	(0.04	)	$	(0.01	)	$	(0.08	)	$	(0.01	)

Weighted Average Common Shares Outstanding
- Basic and Diluted		27,809,200			27,191,676			27,809,200			25,087,820

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

New You, Inc.
Condensed Consolidated Statement of Shareholders’ Deficit

For the Six Months Ended June 30, 2020

(Unaudited)

	Common				Additional Paid			Accumulated			Total Stockholders’
		Shares		Par Value		in Capital			Deficit			Deficit
Balance as of December 31, 2019		32,985,200	$	330	$	1,149,005		$	(2,120,304	)	$	(970,969	)
Stock-based Compensation - Employees		—		—		518,750			—			518,750
Stock-based Compensation - Consultants		458,000		5		246,161			—			246,166
Shares Issued in Connection with Note Payable Issuance		50,000		—		25,000			—			25,000
Net Loss		—		—		—			(964,734	)		(964,734	)
Balance as of March 31, 2020		33,493,200	$	335	$	1,938,916		$	(3,085,038	)	$	(1,145,787	)
Stock-based Compensation - Employees		—		—		518,750			—			518,750
Stock-based Compensation - Consultants		3,796,690		38		176,872			—			176,910
Common Shares Issued for Cash Received in 2019		90,000		1		(1	)		—			—
Shares Issued in Connection with Note Payable Interest Penalties		900,000		9		449,991			—			450,000
Net Loss		—		—		—			(1,155,655	)		(1,155,655	)
Balance as of June 30, 2020		38,279,890	$	383	$	3,084,528		$	(4,240,693	)	$	(1,155,782	)

New You, Inc.
Condensed Consolidated Statement of Shareholders’ Deficit

For the Six Months Ended June 30, 2019

(Unaudited)

	Common				Additional Paid			Accumulated			Total Stockholders’
		Shares		Par Value		in Capital			Deficit			Deficit
Balance as of December 31, 2018		15,974,558	$	160	$	126,840		$	(428,006	)	$	(301,006	)
Effect of Reverse Recapitalization Transaction		10,772,587		108		(16,677	)		—			(16,569	)
Shares Issued Pursuant to Anti-dilution Provision		409,605		4		(4	)		—			—
Net Income		—		—		—			22,271			22,271
Balance as of March 31, 2019		27,156,750	$	272	$	110,159		$	(405,735	)	$	(295,304	)
Sales of Common Shares		179,758		2		79,998			—			80,000
Net Loss		—		—		—			(213,076	)		(213,076	)
Balance as of June 30, 2019		27,336,508	$	274	$	190,157		$	(618,811	)	$	(428,380	)

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

New You, Inc.
Condensed Consolidated Statements of Cash Flows

	For The Six Months Ended			For The Six Months Ended
		June 30,			June 30,
		2020			2019
		(Unaudited)			(Unaudited)
Operating Activities
Net Loss	$	(2,120,389	)	$	(190,805	)
Adjustments to Reconcile Net Loss to Net Cash Used
in Operating Activities:
Depreciation and Amortization		3,327			1,636
Amortization of Operating Lease Right of Use Asset		20,658			—
Amortization of Debt Issuance Costs		25,000			—
Shares Issued in Connection with Note Payable Interest Penalties		450,000
Stock-based Compensation - Employees		1,037,500			—
Stock-based Compensation - Consultants		423,076			—
Changes in Operating Assets and Liabilities:
Credit Card Receivable		(164,625	)		(17,787	)
Inventory		75,464			(70,602	)
Due From Merger Partner		—			10,456
Prepaid Expenses and Other Current Assets		(31,863	)		93,690
Accounts Payable and Other Current Liabilities		(25,299	)		198
Accounts Payable to Related Parties		14,630			—
Operating Lease Liabilities		(3,952	)		—
Net Cash Used in Operating Activities		(296,473	)		(173,214	)
Investing Activities
Purchase of Property and Equipment		—			—
Net Cash Used in Investing Activities		—			—
Financing Activities
Proceeds from Related Party Debt		159,000			78,983
Repayments of Related Party Debt		(186,485	)		—
Sale of Shares		—			80,000
Loan Proceeds, Net of Issuance Costs		323,958			—
Net Cash Provided by Financing Activities		296,473			158,983
Net Increase (Decrease) in Cash		—			(14,231	)
Cash
Beginning of Period		1,125			27,310
End of Period	$	1,125		$	13,079

Supplemental Disclosures
Cash Paid for Interest	$	52,500		$	—
Cash Paid for Income Taxes	$	—		$	—

Non-cash Investing and Financing Activities:
Payroll and Other Payables to Related Parties Converted to Related Party Debt	$	137,100		$	124,364
Related Party Debt Adjusted Against Credit Card Receivables	$	182,015		$	118,692
Shares Issued in Connection with Note Payable Issuance	$	25,000		$	—
Shares Issued in Connection with Late Interest Payments	$	450,000		$	—

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

NEW YOU, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Note 1 – Organization and Summary of Significant Accounting Policies

Nature of Business

New You, Inc., formerly known as The Radiant Creations Group, Inc. (the “Company”) was incorporated in Nevada on December 29, 2005. From inception, the Company's principal business activity was the acquisition and exploration of mineral resources. On June 20, 2013, following a change of control and subsequent acquisition of an exclusive license agreement, the Company changed its principal business to the development and marketing of cosmetics and over-the-counter personal enhancement products and devices. After a change in control on July 11, 2018, the Company changed its principal business to selling cannabidiol (“CBD”) hemp oil-based products through independent business owners (called “Brand Partners”).

The Company, through its wholly owned subsidiary New You LLC, markets and sells its products through a multi-level marketing sales opportunity.

Basis of Presentation

The unaudited condensed consolidated financial statements include the operations of New You, Inc. and its wholly-owned subsidiary, New You LLC. These unaudited condensed consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with Article 10 of Securities and Exchange Commission (SEC) Regulation S-X for Interim Reporting. All intercompany transactions, accounts and profits, if any, have been eliminated in the unaudited condensed consolidated financial statements. In the opinion of management, all adjustments considered necessary for fair statement have been included.

These unaudited condensed consolidated financial statements do not include all disclosures required by GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the more detailed audited financial statements of New You, Inc. for the year ended December 31, 2019, which are included in the Company’s Annual Report on Form 10-K.

The results for the six months ended June 30, 2020 and 2019 are not necessarily indicative of results to be expected for a full year, any other interim periods, or any future year or period.

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates include estimates for future charge-backs and allowance for slow moving or obsolete inventory.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. As of June 30, 2020, the Company had no cash equivalents.

Credit Card Receivables

Credit card receivable consists of only the amount due from the credit card processing companies. There is no need for an allowance for doubtful accounts, since the system and processor makes sure that the transaction is successful prior to the sale being finalized. Accordingly, no allowance was recorded as of June 30, 2020.

Inventory

Inventory consists of finished goods and is valued at the lower of cost or net realizable value. Cost is determined using the first in first out (FIFO) method. Provision for potentially obsolete or slow moving inventory is made based on management analysis or inventory levels and future sales forecasts.

Prepaid Expenses

Prepaid expenses consist of various payments that the Company has made in advance for goods or services to be received in the future. These prepaid expenses primarily consist of deposits on inventory yet to be delivered or shipped.

Property and Equipment

Property and equipment are stated at cost, net of depreciation provided by use of a straight-line method over the estimated useful lives of the assets, which is five years. The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable.

Impairment of Long-Lived Assets

We evaluate the recoverability of long-lived assets in accordance with authoritative guidance on accounting for the impairment or disposal of long-lived assets. We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Such impairment is recognized in the event the net book value of such assets exceeds their fair value. No impairment of long-lived assets occurred in the periods presented.

Revenue Recognition

Revenue is recognized in accordance with ASC 606, Contracts with Customers, by analyzing exchanges with the Company’s customers and Brand Partners using a five-step analysis that includes identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.

The Company recognizes revenue when the customer receives the promised good and all performance obligations are met. Revenue is recognized at an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those services.

The Company records sales of finished products once the customer or Brand Partner places and pays for the order and the product is shipped. Delivery is considered to have occurred when title and risk of loss have transferred to the customer, which is upon shipment of the product. The Company treats shipping expenses as costs to fulfill a contract, so that revenue is recognized gross of shipping expenses. The Company recognizes revenue net of sales taxes.

The Company and its Brand Partners agree to provide customers with a 100% satisfaction guaranteed policy that allows the customer sixty days from the sales transaction to return the product and receive a 100% refund, and one year for a Brand Partner to get a 90% refund, as long as the product remains in saleable condition and the Brand Partner or the Company have not cancelled the Brand Partner agreement. The Company records an estimate for provisions of returns and other adjustments for each shipment, which is netted with gross sales. The Company accounts for such provisions during the same period in which the related revenues are earned. The Company has determined that the population of contracts with the Company’s customers and Brand Partners tends to be homogenous, so that review of the contracts and estimate of various revenue related adjustments can be applied to the entire population. The Company had customer returns of approximately $42,500 for the six months ended June 30, 2020 and approximately $39,000 for the six months ended June 30, 2019. The Company has not recorded a reserve for returns at June 30, 2020 or December 31, 2019 since it does not believe such returns will be material.

As of June 30, 2020, the Company did not have any in-process or prepaid sales orders or transactions that would require the recognition of a contract liability.

Cost of Revenue

Amounts recorded as cost of revenue relate to direct expenses incurred in order to fulfill orders of our products. Such costs are recorded as incurred. Our cost of revenue consists primarily of the cost of product, and the cost of product samples.

Commission Expense and Contract Acquisition Costs

The Company markets and sells its products through a direct sales opportunity afforded to Brand Partners through a multi-level marketing sales platform. Commissions are earned on product sales to Brand Partners and customers at a rate of 10% for every transaction plus a specified spread on recurring sales. Brand Partners earn a 5% commission on sales by other team members at lower levels up to nine levels below the Brand Partner. Brand Partners can earn an additional bonus for customer sales and team sales. The team bonus is $400 for each time their team bonus volume reaches a certain amount in a 30 day period. Brand Partners can also earn an initial bonus for qualifying customer purchases in the Brand Partners’ first 30 days of 20% of the transaction value.

The Company expenses commissions in accordance with ASC 606, Contracts with Customers. Commissions are accrued upon shipment of the product to either the Brand Partner or the customer.

Advertising Expenses

The Company expenses advertising costs as incurred in accordance with ASC 720-35, “Other Expenses – Advertising Cost.” Advertising expenses totaled $6,586 for the six months ending June 30, 2020 and $10,544 for the six months ended June 30, 2019.

Operating Lease

A lease provides the lessee the right to control the use of an identified asset for a period of time in exchange for consideration. Right of use (ROU) assets represent the Company's right to use an underlying asset for the lease term and operating lease liabilities represent the Company's obligation to make lease payments arising from the lease. The Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Most operating leases contain renewal options that provide for rent increases based on prevailing market conditions. The lease term used to calculate the ROU asset includes renewal periods or periods subject to termination when it is reasonably certain that the Company will lease the assets in such periods.

The discount rate used to determine the commencement date present value of lease payments is the interest rate implicit in the lease, or when that is not readily determinable, the estimated incremental secured borrowing rate. ROU assets include any lease payments required to be made prior to commencement and exclude lease incentives. Both ROU assets and lease liabilities exclude variable payments not based on an index or rate, which are treated as period costs. The Company's lease agreements do not contain significant residual value guarantees, restrictions or covenants.

Stock Compensation Expense

ASC 718, Compensation – Stock Compensation, prescribes accounting and reporting standards for all share-based payment transactions. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values at the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, Equity – Based Payments to Non-Employees. Measurement of share-based payment transactions with non-employees is based on the fair grant date FV of equity instruments. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date. Share-based compensation expense for the six months ended June 30, 2020 and 2019 was $1,460,576 and $0.

Basic and Diluted Net Loss and Income Per Share

Basic net loss or income per share is calculated by dividing the net loss or income attributable to common stockholders by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss or income per share is computed by dividing the net loss or income attributable to common stockholders by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method.

The following table presents the computation of basic and diluted net loss or income per common share:

	For The Three Months Ended						For The Six Months Ended
	June 30,						June 30,
	2020			2019			2020			2019
Historical net loss per share
Numerator
Net loss		(1,155,655	)		(213,076	)		(2,120,389	)		(190,805	)
Denominator
Weighted-average common shares outstanding		35,237,476			27,191,676			34,206,607			25,087,820
Less: Weighted-average restricted shares		(7,428,276	)		—			(6,397,407	)		—
Denominator for basic and diluted net loss per share		27,809,200			27,191,676			27,809,200			25,087,820
Basic and diluted net loss per share	$	(0.04	)	$	(0.01	)	$	(0.08	)	$	(0.01	)

Potentially dilutive securities that are not included in the calculation of diluted net loss or income per share because their effect is anti-dilutive are as follows (in common equivalent shares):

	For The Three Months Ended				For The Six Months Ended
	June 30,				June 30,
	2020		2019		2020		2019
Restricted shares		7,428,276		—		6,397,407		—

Note 2 – Going Concern

We incurred a net loss for the six months ended June 30, 2020 and had an accumulated deficit of $4,240,693 at June 30, 2020 of which $2,138,180 was related to non-cash stock based compensation. At June 30, 2020, we had a cash balance of approximately $1,125, compared to a cash balance of $1,125 at December 31, 2019. At June 30, 2020, we had a working capital deficit of $1,184,168 compared to a working capital deficit of $1,055,049 at December 31, 2019.

We have not been able to generate sufficient cash from operating activities to fund our ongoing operations. We will be required to raise additional funds through public or private financing, additional collaborative relationships or other arrangements until we are able to raise revenues to a point of positive cash flow. We are evaluating various options to further reduce our cash requirements to operate at a reduced rate, as well as options to raise additional funds, including obtaining loans and selling common stock. There is no guarantee that we will be able to generate enough revenue and/or raise capital to support operations.

Based on the above factors, substantial doubt exists about our ability to continue as a going concern for one year from the issuance of these financial statements.

Note 3 – Concentrations of Business and Credit Risk

The Company at times maintains balances in various operating accounts in excess of federally insured limits.

The Company monitors its positions with, and the credit quality of, the financial institutions with which it invests.

Substantially all of the Company’s revenues are to unique customers or Brand Partners. Since the Company sells its products to a large number of customers, there is no revenue concentration from customers. However, the Company uses merchant processors to charge customer credit cards and does contain concentration risk between credit card processors. As of June 30, 2020, one credit card processor accounted for 100% of Credit Card Receivables. We have added one other processor and will begin processing through both processors as sales grow. We are in the process of adding more processors when they become available.

The Company also made purchases from and has accounts payable to Carlsbad Naturals, LLC as described in Note 6.

Note 4 – Equity

June 30, 2020 Restricted Stock Grants

During the six months ended June 30, 2020, the Company issued 4,254,690 common shares for several consultants for services that will be provided in the future and will vest over the course of between twelve and twenty four months, of which 4,179,690 shares were granted during the six months ended June 30, 2020 and 75,000 shares were granted in 2019. The Company estimated the fair value of the shares at $0.50 per share based on the price at which the Company issued common shares for cash in 2019 and not based on the amount that shares were trading for on the OTC “Pink” market since shares were thinly traded on the market from August 2019 to June 2020 when the equity instruments were granted. There were no grants of restricted stock to employees or consultants during the first or second quarter of 2019.

The table below summarizes the activity of the restricted stock during the six months ended June 30, 2020:

	Number of Shares		Weighted Average Fair Value per Share
Nonvested as of January 1, 2020		5,151,000	$	0.50
Granted		4,179,690		0.50
Vested		—		0.50
Forfeited		—		—
Nonvested as of June 30, 2020		9,330,690	$	0.50

For the six months ended June 30, 2020 the compensation costs that has been charged to Stock Compensation Expense is $1,460,576. No portion of the total compensation cost was capitalized. The unrecognized compensation costs as of June 30, 2020 is $2,520,185 , which will be amortized over a weighted average period of 17.6 months. The company recognizes the cost of these stocks using the straight line method and forfeitures are recognized as they occur.

Note 5 - Debt

During the six months ended June 30, 2020, the Company received loan proceeds of $125,000 pursuant to a promissory note with a maturity date of June 15, 2020 and interest of $4,167 per month. The note’s terms required that the Company issue 50,000 common shares, and allowed the noteholder to convert the note into common shares at a conversion price of $0.50 per share. This note was not paid off as of June 30,2020. The Company is still making the agreed upon interest payments of $4,167 per month and there are no penalties for not paying the note off by its maturity date.

During the six months ended June 30, 2020, the Company received loan proceeds of $100,000 from a related party pursuant to a promissory note with a maturity date of April 7, 2020 and interest of $5,000 per month. If the Company defaults on the loan, the note’s terms require the Company to issue default shares of 100,000 each time the company is late on its interest payment, 250,000 shares if it is late on principal repayment, and 100,000 shares each subsequent month that repayment has not occurred. The amount of the foregoing shares is doubled if the stock price falls below $1.00, and may also increase significantly the Company’s outstanding common shares exceed 40,000,000. In addition, the Company will incur a 15% charge each year that repayment has not occurred. The terms also lay out a blanket lien on all assets of New You, Inc. including all the shares of New You LLC., all the assets of New You LLC and all shares of any acquired companies in the future as well as all of their assets. Further, the note requires that the full balance be repaid in order for a change in control to be consummated. During the six months ended June 30, 2020, the amount of penalty shares issued were doubled due to the stock price falling below $1.00. In total, the Company issued a total of 900,000 shares to the related party during the six months ended June 30, 2020 per the agreement: 500,000 shares due to late repayment of the note, and 400,000 shares due to late payment of two months of interest payments. The Company paid off $50,000 of this note during the six months ended June 30, 2020 and the interest payments are now $2,500 per month.

During the six months ended June 30, 2020, the Company received one Paycheck Protection Program loan in the amount of $103,958 with a maturity date of May 21, 2022 and interest rate of 1%. Monthly payments of $5,850 will begin on December 21, 2020 and end on the maturity date. All or a portion of this loan may be forgiven if the Company satisfies certain criteria.

During the six months ended June 30, 2020, the Company received a non-interest bearing advance from the Small Business Administration under the Emergency Injury Disaster Loan program of $10,000. All or a portion of this loan may be forgiven if the Company satisfies certain criteria.

During the six months ended June 30, 2020 the Company received $85,000 in loan proceeds, which is net of $3,000 in debt issuance costs, pursuant to a loan agreement with a maturity date of June 17, 2020 and an interest rate of 8% per annum from the date of issuance until maturity date. Any amount of principal or interest on this note which is not paid when due shall bear interest at the rate of 22% per annum from the due date until the full amount is paid. Upon certain events of default, the Company may be obligated to repaid double the outstanding principal and interest balance on the note. The holder may convert the note to common shares starting 180 days after the issuance date at a conversion price equal to 61% of the lowest trading price in the last 20 trading days.

Note 6 – Commitments and Contingencies

Operating Lease Commitments

The Company leases a warehouse facility under a lease agreement that expires July 31, 2021. The Company does not have any significant capital leases.

The components of total lease cost were as follows:

Operating Lease Cost
		Six Months Ended June 30,		Six Months Ended June 30,
		2020		2019
Operating lease cost		37,226		37,226
Total lease cost	$	37,226	$	37,226

Cash paid for amounts included in operating lease liabilities was $20,520 and $37,164 for the six months ended June 30, 2020 and June 30, 2019 respectively. Due to COVID-19, the Company was permitted to pay only common area maintenance charges in April through June, totaling $474 each month. The Company is working with the property manager to come to an agreement on how to pay the amount of rent that was not paid during the second quarter of 2020. It is not known at this time how the unpaid balance will be paid. The table below presents total operating lease ROU assets and lease liabilities as of June 30, 2020:

Right Of Use Assets and Liability
	June 30, 2020
Operating lease ROU assets	$	75,652
Operating lease liabilities		97,483

The table below presents the maturities of operating lease liabilities as of June 30, 2020

For the twelve months ended June 30,
	2021	76,386
	2022	26,101
	2023	—
	2024	—
	2025	—
	Thereafter	—
	Total Lease Payments	102,487
	Less: Discount	(5,004	)
	Total Operating Lease Payments	97,483

The table below presents the weighted average remaining lease term for operating leases and weighted average discount rate used in calculating operating lease right-of-use assets:

	June 30, 2020
Weighted average remaining lease term (years)	1.08
Weighted average discount rate	7	%

Litigation and Claims

The Company may be involved in lawsuits and claims arising in the ordinary course of business from time to time. The Company reviews any such legal proceedings and claims on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies where the incurrence of a loss is probable and can be reasonably estimated, and it discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for the Company’s financial statements not to be misleading. To estimate whether a loss contingency should be accrued by a charge to income, the Company evaluates, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of the loss. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon present information, the Company determined that there were no matters that required an accrual as of June 30, 2020 or 2019, nor were there any asserted or unasserted material claims for which material losses are reasonably possible.

Note 7 – Related Party Transactions

During the six months ended June 30, 2020 and 2019, directors and members of management provided loans to the Company or paid for various expenses of the Company. These loans contained no interest, term or due date. As of June 30, 2020, these loans had a combined balance of $374,747 for the CEO, the President, and two other board members. Total additions to these loans during the six months ended June 30, 2020 were $196,100, including cash loan proceeds of $59,000 and deferred compensation of $137,100 transferred from accounts payable to related parties to related party debt. Total cash repayments for the six months ended June 30, 2020 were $121,100. The Company also offset $182,015 of related party debt against receivables and made payments of $15,385 to an officer that were applied against the a loan to a director during the six months ended June 30, 2020. As of December 31, 2019, these loans had a combined balance of $497,147 for the CEO, the president, and two other board members. Total additions to these loans during the six months ended June 30, 2019 were $220,672 including cash loan proceeds of $78,000 and deferred compensation of $124,364 transferred from accounts payable to related parties to related party debt, and $18,308 of expenses paid on the Company’s behalf. The Company also offset $118,692 of related party debt against receivables during the six months ended June 30, 2019.

As of June 30, 2020 and December 31, 2019, we also owed $50,635 and $78,105 to Carlsbad Naturals, LLC (included in accounts payable to related parties), which is a principal shareholder of New You, Inc. and is owned by a principal shareholder of New You, Inc., for inventory purchases. During the six months ended June 30, 2020 and six months ended June 30, 2019 we made purchases of $53,896 and $142,313 from Carlsbad Naturals, LLC. As of June 30, 2020 and December 31, 2019, we owed $27,500 and $22,500 for consulting payments to a relative of the CEO.

During the six months ended June 30, 2020, the Company received a loan from a board member’s family member in the amount of $100,000 and repaid $50,000 of this balance. A total of $25,000 was paid in interest for the loan during the six months ended June 30, 2020.

The Company leases and pays for a warehouse facility where it shares space with Carlsbad Naturals, LLC. In exchange, Carlsbad Naturals, LLC leases and pays for an office facility where it shares space with the Company. As a result of this arrangement, the Company has recorded rent expense in the accompanying statements of operations for the lease that it is responsible for paying.

During 2018 and the first five months of 2019, along with the months of April, May, June, and July 2020, all credit card receivable payments were processed through the bank account of one of the founding members due to the frequent bank account changes that were occurring with the Company’s accounts. All funds received into the founder’s bank account was transferred directly to the Company’s account on a weekly basis and have been accounted for. Between May 31, 2019 and April 4, 2020 and after July 31, 2020, all credit card receivables were deposited by the credit card processor directly into the Company’s bank account. The balance due from the related party at June 30, 2020 was $182,015.

Note 8 – Subsequent Events

The Company has evaluated subsequent events through August 18, 2020, which is the date the financial statements were issued. The Company has determined that there were no subsequent events which required recognition or disclosure in the financial statements, except as disclosed below.

Subsequent to June 30, 2020, the Company issued 45,000 common shares for services to be performed in the future.

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and supplementary data referred to in this Form 10-Q.

This discussion contains forward-looking statements that involve risks and uncertainties. Such statements, which include statements concerning revenue sources and concentration, selling, general and administrative expenses and capital resources, are subject to risks and uncertainties, including, but not limited to, those discussed elsewhere in this Form 10-Q that could cause actual results to differ materially from those projected. Unless otherwise expressly indicated, the information set forth in this Form 10-Q is as of June 30, 2020, and we undertake no duty to update this information.

New You, Inc.’s principal business is the marketing of unique and proprietary cannabidiol (“CBD”) products, which include CBD beverage enhancers that can be added to any beverage, CBD infused coffee, and CBD oil tinctures. The Company has five products:

DROPS - 220 mgs of CBD – odorless, tasteless, flavorless and can be added to any beverage or liquid.

CB2 & CBD 2 Plus - A Multi Spectrum Hemp-extracted CBD and Beta-Caryophyllene (β-Caryophyllene is the primary sesquiterpene contributing to the spiciness of black pepper; it is also a major constituent of cloves, hops, rosemary, copaiba, and cannabis), naturally blended coconut-derived MCT oil (made from a coconut fat called medium-chain triglyceride) and a hint of peppermint.

Drops for Pets - This 50 mgs CBD product is designed to be used by pets.

ENDO30 –

CAFFE CANNA - Caffe Canna is a rich organic CBD-infused non-GMO dark roast coffee

ABSORB – Made of a Japanese root and rice flour veggie capsule.

RELEASE - Made with organic Clove, Cascara Sagrada, Agave Inulin, Rhubarb Root Extract, Slippery Elm Bark, Aloe Vera and other herbs.

Drops FX –Our proprietary blend of CBD and Vitamins B3, B6, B9 & B12, that you can use in any drink or liquid.

Drops FX Sleep –A blend of CBD, GABA (Gamma-amino butyric acid is an amino acid in the body that acts as a neurotransmitter in the central nervous system), Melatonin, Valerian Root.

NanoX – A water soluble, Full Spectrum DBD made with Purified Water, NanoX™ Liposomal Hemp Complex (Hemp Extracts, Purified Water, Gum Acacia, MCT Oil (from Coconut)), Colloidal Silver (20ppm), Liposomal Methyl B12, Liposomal CoQ10, Liposomal Curcumin, Stevia Leaf Extract.

The Cream – A topical skin cream made with Cannabidiol (1,000 mg of whole plant CBD isolate per 60 mL), Purified Water (Aqua), Glyceryl Stearate SE, Cannabis Sativa (Hemp) Seed Oil, Cocos Nucifera (Coconut) Oil, Ethyl Macadamiate, Stearic Acid, Cetearyl Alcohol, Pentylene Glycol, Oryza Sativa (Rice) Bran Extract, Tocopherol, Eucalyptus Globulus Leaf Oil, Origanum majorana, Potassium Hydroxide, Hydroxypropyl Starch Phosphate, Phenoxyethanol, Caprylyl Glycol, Tetra- sodium Glutamate Diacetate, Pentanediol

New You, Inc. through its wholly owned subsidiary, New You LLC, markets and sells its products through a multi-level marketing and direct sales opportunity afforded to independent business owners called “Brand Partners.” Commissions are earned on product sales to Brand Partners and their customers at a rate of 10% for every transaction, plus a specified spread on recurring sales. Brand Partners earn a 5% commission on sales by other team members at lower levels up to nine levels below the Brand Partner. Brand Partners can earn an additional bonus for customer sales and team sales. The team bonus is $400 for each time the team bonus volume reaches a certain amount in a 30 day period. Brand Partners can also earn an initial bonus of 20% of the transaction value for qualifying Brand Partners in the Brand Partner’s first 30 days. There is a risk that Brand Partners may find it difficult to sell in a network marketing environment. Brand Partners may also find it difficult to sell CBD related products due to the uncertainty surrounding FDA regulations of CBD and hemp related products. Lastly, public perception of CBD products may be negative, as such products are derived from the Hemp plant. The Company does not hold any patents or trademarks and, as a result, may be vulnerable to competition from other companies offering very similar products and product brands The Company purchases inventory from Carlsbad Naturals, LLC. Carlsbad Naturals, LLC is a principal shareholder of New You, Inc., and is owned by a principal shareholder of New You, Inc. As a result, we are dependent on a related party for product inventory and do not have a broad base of unaffiliated suppliers. The officers and directors of the Company own 43.81% of the outstanding common shares. Accordingly, management will have a determinative influence on matters requiring shareholder approval.

Results of Operations

Revenues. For the three months ended June 30, 2020, we generated revenues of $544,600, a decrease of $184,404 compared to revenues of $729,004 for the three months ending June 30, 2019. Comparing the six months ended June 30, 2020 to June 30, 2019, total revenue decreased $382,778 with a revenue of $1,076,123 for the six months ended June 30, 2020 compared to $1,458,901 for the six months ended June 30, 2019. The decrease was primarily due to a major systems change and the COVID-19 shutdown. At this stage in our development, revenues are not yet sufficient to cover ongoing operating expenses.

Gross Profit. Our gross profit for the three months ended June 30, 2020 was $494,593, a decrease of $104,265 compared to the three months ended June 30, 2019. Our gross margin percentage for the three months ended June 30, 2020 was 91%, compared to 82% for the three months ended June 30, 2019. The change in gross margin in the three months ended June 30, 2020 compared to the three months ended June 30,2019 was due to the sales of lower margin items slowing down and the sales of the Company’s higher margin items staying flat. Comparing the six months ended June 30,2020 to June 30, 2019, gross profit decreased $213,763 with a gross profit of $944,274 during the six months ended June 30, 2020 compared to $1,158,037 for the six months ended June 30, 2019. Our gross margin percentage for the six months ended June 30, 2020 was 88%, compared to 79% for the six months ended June 30, 2019. The change in gross margin in the six months ended June 30, 2020 compared to the six months ended June 30,2019 was due to the sales of lower margin items slowing down and the sales of the Company’s higher margin items staying flat

Selling, General, and Administrative Expenses. Selling, general, and administrative expenses (“SG&A expenses”) for the three months ended June 30, 2020 were $1,158,848, an increase of $346,914 compared to the three months ended June 30, 2019. For the three months ended June 30, 2020, the components of SG&A expenses were: (i) a reduction in commission expenses; (ii) a reduction in payroll expenses; and (iii) and an increase in other SG&A expenses. Non-cash stock based compensation for the three months ended June 30, 2020 was $695,660, there was no stock based compensation for the three months ended March 31, 2019. In Comparing the six months ended June 30, 2020 to June 30, 2019, SG&A expenses were $2,540,530 compared to $1,348,042, an increase of $1,192,488. The main cause of the increase was the non-cash stock based compensation expensed during the six months ended June 30, 2020 of $1,460,576.

	For the three months ended	For the three months ended	For the six months ended	For the six months ended
	June 30,	June 30,	June 30,	June 30,
	2020	2019	2019	2020
Staff and Overhead Expenses	284,259	506,272	688,857	819,967
Accounting/Legal	16,975	34,875	81,453	53,760
Commission Expense	161,954	270,787	309,644	474,315
Non-Cash Stock Based Compensation	695,660	—	1,460,576	—
	1,158,848	811,934	2,540,530	1,348,042

Operating Loss. We realized an operating loss of $664,255 before interest and income taxes for the three months ended June 30, 2020 compared to operating loss of $213,076 for the three months ended June 31, 2019. For the six months ended June 30, 2020, we realized an operating loss of $1,596,256 compared to an operating loss of $190,005 for the six months ended June 30, 2019.

Interest Expense. Interest expenses for the three months ended June 30, 2020 were $491,400 compared to $0 for the three months ended June 30, 2019. During the three months ended June 30, 2020, $450,000 in common stock was issued as a penalty for late interest payments and for the stock price falling below $1. Interest expenses for the six months ended June 31, 2020 were $523,333 compared to $0 for the six months ended June 30, 2020. There were no interest bearing loans in 2019.

Net Loss. We incurred a net loss of $1,155,655 for the three months ended June 30, 2020 compared to net loss of $213,076 for the three months ended June 30, 2019. The primary reason for the increase in net loss is due to the major system changes, COVID-19, $450,000 in interest expenses related to common stock issued as a penalty for late interest payments and the stock price falling below $1, and a total of $764,916 of non-cash stock based compensation expenses. We incurred a net loss of $2,120,389 for the six months ended June 30, 2020 compared to a net loss of $190,805 for the six months ended June 30, 2019. Management will continue to make an effort to lower operating expenses and increase revenue.

Liquidity and Capital Resources

We incurred a net loss for the six months ended June 30, 2020 and had an accumulated deficit of $4,240,693 at June 30, 2020. At June 30, 2020, we had a cash balance of approximately $1,125, compared to a cash balance of $1,125 at December 31, 2019. At June 30, 2020, we had a working capital deficit of $1,184,168, compared to a working capital deficit of $1,055,049 at December 31, 2019. Our existing and available capital resources are not expected to be sufficient to satisfy our funding requirements through one year from the date of this filing in the absence of share issuances or other sources of financing.

We have not been able to generate sufficient cash from operating activities to fund our ongoing operations. Since our inception, we have raised capital through private sales of preferred stock, common stock, and debt securities.

We will be required to raise additional funds through public or private financing, additional collaborative relationships or other arrangements until we are able to raise revenues to a point of positive cash flow. We are evaluating various options to further reduce our cash requirements to operate at a reduced rate, as well as options to raise additional funds, including obtaining loans and selling common stock. There is no guarantee that we will be able to generate enough revenue and/or raise capital to support its operations.

Based on the above factors, substantial doubt exists about our ability to continue as a going concern for one year from the issuance of these financial statements.

The issuance of additional securities may result in a significant dilution in the equity interests of our current stockholders. Obtaining loans, assuming these loans would be available, will increase our liabilities and future cash commitments. There is no assurance that we will be able to obtain further funds required for our continued operations or that additional financing will be available for use when needed or, if available, that it can be obtained on commercially reasonable terms.

The effect of existing or probable government regulations on our business is not known at this time. Due to the nature of our business, it is anticipated that there may be increasing government regulation that may cause us to have to take serious corrective actions or make changes to the business plan.

Cash Flow

The following table summarizes our cash flows for the periods indicated below:

	For the Six Months Ended			For the Six Months Ended
	June 30,			June 30,
	2020			2019
Cash used in operating activities		(296,473	)		(173,214	)
Cash used in investing activities		—			—
Cash provided by financing activities		296,473			158,983

Cash Used in Operating Activities

During the six months ended June 30, 2020 cash used in operating activities of $296,473 primarily reflected our net losses for the period, adjusted by non-cash charges such as depreciation and stock-based compensation, as well as changes in our working capital accounts, primarily consisting of a decrease in inventory, an increase in prepaid expenses and other current assets, and an increase in accounts payable, an increase in credit card receivables and an increase in receivables due from a related party.

During the six months ended June 30, 2019 cash used in operating activities of $173,214 primarily reflected our net losses for the period, adjusted by non-cash charges such as depreciation, as well as changes in our working capital accounts, primarily consisting of a decrease in inventory, an increase in credit card receivables, a decrease in prepaid expenses, and a decrease in accounts payable.

In April 2020, our credit card processor requested that we maintain a minimum balance in our bank account that we could not meet. As a result, the Company temporarily changed the bank account registered with the credit card processor to one of our board member’s personal bank accounts so that the processor would continue processing payments. The board member made daily or weekly deposits depending on the days the bank was open. Near the end of June 2020, there was an issue with the deposits and multiple days were held in transit causing a larger than normal balance in the credit card receivables account. These deposits were cleared in the beginning of July 2020 and the bank account with the processor was switched back to the Company’s operating account on July 31, 2020.

Cash Used in Investing Activities

During the six months ended June 30, 2020 and 2019, there was no cash used in investing activities.

Cash Provided by Financing Activities

During the six months ended June 30, 2020, cash provided by financing activities was $296,473, which consisted primarily of proceeds from related party debt, proceeds from a grant, one PPP loan, and proceeds from two loans from unrelated parties received in January 2020 and June 2020.

During the six months ended June 30, 2019, cash provided by financing activities was $158,893, which consisted of proceeds from related party debt and repayments of related party debt and the sale of common stock.

Recent Accounting Pronouncements

None.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

As of June 30, 2020, the end of the period covered by this Quarterly Report on Form 10-Q, our management, with the participation of our Chief Executive Officer and Chief Accounting Officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this annual report. Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to the company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Accounting Officer concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this annual report at the reasonable assurance level.

Material Weakness in Internal Control over Financial Reporting

The Company lacks an effective control environment since there are insufficient personnel to exercise appropriate oversight of accounting judgments and estimates.

Due to limited accounting and financial reporting resources, the Company lacks formal processes to identify, update, and assess risks to the Company’s financial reporting.

Due to limited accounting and financial reporting resources, the Company has not implemented significant monitoring controls.

Due to limited accounting and financial reporting resources, authorization, approval, and review controls over the Company's financial statements and accounting records have not been implemented or have not been applied consistently. This includes controls over the identification, approval, and disclosure of related party transactions. In certain cases, formal documentation does not exist regarding the design of controls, evidence of implementation of controls, or evidence of occurrence of certain transactions. In addition, certain of the Company’s processes lack segregation of duties.

Changes in Internal Control over Financial Reporting

Other than with respect to the remediation efforts discussed below, there was no change in our internal control over financial reporting that occurred during the fourth quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Remediation of Previous Material Weaknesses

We have implemented and will continue to implement a number of measures to address the Material Weaknesses identified as of March 31, 2020. We plan on updating internal policies and procedures and create an effective control environment, add outside consultants, as needed to bolster technical accounting needs, and ass more personnel, as needed to segregate duties.

Limitations on Effectiveness of Controls and Procedures

Our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving the desired control objectives. Our management recognizes that any control system, no matter how well designed and operated, is based upon certain judgments and assumptions and cannot provide absolute assurance that its objectives will be met. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs. Similarly, an evaluation of controls cannot provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.

PART II - OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

None.

ITEM 1A.

RISK FACTORS

Not applicable to smaller reporting companies.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.

MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.

OTHER INFORMATION

None.

ITEM 6.

EXHIBITS

The following exhibits are included as part of this report:

	31.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
	31.2	Certification of Chief Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
	32.1	Certification of Chief Executive Officer and Chief Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
	101.INS	XBRL Instance Document(1)
	101.SCH	XBRL Taxonomy Extension Schema Document(1)
	101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document(1)
	101.LAB	XBRL Taxonomy Extension Label Linkbase Document(1)
	101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document(1)
	101.DEF	XBRL Taxonomy Extension Definition Linkbase Definition(1)

(1) Filed Herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: August 18, 2020

	NEW YOU, INC.

	By:	/S/ Ray Grimm, Jr.
		Ray Grimm, Jr.
		Chief Executive Officer
		(Principal Executive Officer)

	By:	/S/ James Sinkes
		James Sinkes
		Chief Accounting Officer
		(Principal Financial Officer)